Navigation Links
Biotechnology Builds a New Heart
Date:1/13/2008

Stem cells injected into 'skeleton' of animal organ was beating in just 8 days

SUNDAY, Jan. 13 (HealthDay News) -- An organ-building biotechnology that could create transplantable hearts using stem cells from the recipients themselves has passed important laboratory tests, researchers report.

The technique, called whole organ decellularization, has been used to create functioning heart tissue, according to a report in the Jan. 13 issue of Nature Medicine by a team at the University of Minnesota Center for Cardiovascular Repair.

What the scientists did first was to use detergents and other chemicals to wash out all the old heart cells from rat and pig hearts, explained lead investigator Doris Taylor, who is director of the center. What was left was a scaffold of tubes that once were the organ's blood vessels. Stem cells were then injected into that scaffold, where they were supplied with nutrients that allowed them to grow to create a new organ. Within eight days, the hearts were pumping.

The basic technology is not new, Taylor said. It is being used to create many of the heart valves that are implanted in current operations, she said. However, heart valves are relatively small.

"We have done it on the scale of a pig heart, which is the size and scale of a human heart," she said. "A human heart would be the next step, but we want to perfect the technique first."

The Minnesota researchers have applied for a patent on the combination of agents they use to decellularize an organ the size of a human heart and provide nutrients to the implanted stem cells.

"Multiple things" must be done before a human trial can be attempted, Taylor said. "We are moving to larger organs, making sure we can get enough cells in to repopulate the entire heart, and also, if it is transplantable, to keep it alive for a long time," she said.

The biotechnology might be able to bypass a major impediment to organ transplants, the need to use tissue that is compatible with a recipient's immune system, Taylor said. "In theory, we could be able to use stem cells from a recipient's body to regenerate a heart," she said. "We could rebuild a heart that is immunologically similar to yours."

The Minnesota work "fits right in with other work in regenerative medicine," said Dr. Stephen Badylak, a professor of surgery at the University of Pittsburgh McGowan Institute for Regenerative Medicine. The center, like a number of relatively new facilities around the country, concentrates on work with stem cells, which have the potential of becoming almost any specialized cell within the body.

"Stem cells will respond depending on what they see around them," Badylak said. "What they are doing is to provide a lot of favorable signals for stem cells to become heart cells. They take stem cells that want to become heart cells and make them act appropriately. It sounds great."

In the United States, 5 million people live with heart failure, and roughly 50,000 of those patients die each year while awaiting a donor heart, according to the study.

The newly reported work "provides great proof of principle that you can get heart tissue to form," Badylak said. "The next key is to say how you can use this information therapeutically. The next proof of principle is to put it into a patient that needs it."

The schedule for such an attempt is not clear, Taylor said. "We are certainly several years away, but not tens of years away" from a human transplant trial, she noted.

More information

Basic facts about stem cells are provided by the National Institutes of Health.



SOURCES: Doris Taylor, Ph.D., director, University of Minnesota Center for Cardiovascular Repair, Minneapolis/St. Paul; Stephen Badylak, M.D., professor, surgery, University of Pittsburgh McGowan Institute for Regenerative Medicine; Jan. 13, 2008, Nature Medicine


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Biotech Company Builder Papadopoulos Says Investment in Innovation Needed to Advance Drug Pipeline at Massachusetts Biotechnology Councils Ninth Annual MASS Opportunities Investment Conference
2. UCLA, Tokyo University nanobiotechnology symposium at UCLA to highlight advances in nanomedicine
3. Not just humans benefit from animal biotechnology
4. MichBio Announces Formation of Biotechnology Legislative Caucus
5. Spectrum Pharmaceuticals to Present at the Biotechnology Industry Organization Investor Forum
6. Telecommunications Technology Boosts Revenue Generation by Billions and Builds Positive Brand Experience
7. SYMX Builds on Top of New Microsoft Technologies to Offer Hospitals Real-Time Business and Patient Safety Solutions Using RFID Data
8. Fat Builds Up in Hearts Before Diabetes Onset
9. Priming Heart Before an Attack Could Limit Damage
10. American Heart Association President Urges Congress to Support Preventative Measures to Reduce Risk Factors for the Nations No. 1 Killer
11. Glory Foods Receives Heart Healthy Certification
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Biotechnology Builds a New Heart
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is ... Road To Recovery® program to drive cancer patients to and from their cancer treatments. ... the highest quality of life and ongoing independence. Getting to and from medical ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
(Date:6/23/2016)... -- Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas is ...
Breaking Medicine Technology: